Healthcare provider profile · identity verified

Richard Myint, DO

Internal Medicine · NEW YORK, NY · NPI 1134284813

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	906	134
Amlodipine Besylate	Amlodipine Besylate	756	122
Losartan Potassium	Losartan Potassium	569	92
Metformin Hcl	Metformin Hcl	460	65
Omeprazole	Omeprazole	413	83
Januvia	Sitagliptin Phosphate	275	33
Albuterol Sulfate Hfa	Albuterol Sulfate	263	48
Alendronate Sodium	Alendronate Sodium	221	29
Metoprolol Succinate	Metoprolol Succinate	201	32
Atenolol	Atenolol	199	30
Glipizide Er	Glipizide	193	28
Tamsulosin Hcl	Tamsulosin Hcl	185	22
Hydrochlorothiazide	Hydrochlorothiazide	163	29
Fluticasone Propionate	Fluticasone Propionate	148	43
Lisinopril	Lisinopril	141	21
Enalapril Maleate	Enalapril Maleate	128	13
Raloxifene Hcl	Raloxifene Hcl	127	16
Gabapentin	Gabapentin	124	16
Triamcinolone Acetonide	Triamcinolone Acetonide	121	45
Levothyroxine Sodium	Levothyroxine Sodium	108	16
Ammonium Lactate	Ammonium Lactate	106	18
Alcohol Prep Pads	Alcohol Antiseptic Pads	98	17
Vascepa	Icosapent Ethyl	95	15
Esomeprazole Magnesium	Esomeprazole Magnesium	94	15
Nifedipine Er	Nifedipine	86	16
Azelastine Hcl	Azelastine Hcl	80	11
Hydralazine Hcl	Hydralazine Hcl	80	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	78	suppressed
Trazodone Hcl	Trazodone Hcl	77	15
Finasteride	Finasteride	75	suppressed
Azithromycin	Azithromycin	73	56
Allopurinol	Allopurinol	72	suppressed
Farxiga	Dapagliflozin Propanediol	72	12
Glipizide	Glipizide	66	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	66	17
Clobetasol Propionate	Clobetasol Propionate	64	13
Vitamin D2	Ergocalciferol (Vitamin D2)	63	15
Jardiance	Empagliflozin	60	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	54	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	54	suppressed
Colchicine	Colchicine	53	suppressed
Ibuprofen	Ibuprofen	53	24
Sertraline Hcl	Sertraline Hcl	49	suppressed
Montelukast Sodium	Montelukast Sodium	47	suppressed
Meclizine Hcl	Meclizine Hcl	43	13
Bepotastine Besilate	Bepotastine Besilate	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	suppressed
Simvastatin	Simvastatin	41	suppressed
Eliquis	Apixaban	39	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	37	suppressed
Meloxicam	Meloxicam	36	23
Diclofenac Epolamine	Diclofenac Epolamine	33	suppressed
Dutasteride	Dutasteride	32	suppressed
Folic Acid	Folic Acid	32	suppressed
Famotidine	Famotidine	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Lidocaine	Lidocaine	30	suppressed
Procto-Med Hc	Hydrocortisone	29	suppressed
Furosemide	Furosemide	28	12
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Halobetasol Propionate	Halobetasol Propionate	26	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	26	suppressed
Naproxen	Naproxen	26	suppressed
Repaglinide	Repaglinide	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	17
Benazepril Hcl	Benazepril Hcl	24	suppressed
Clemastine Fumarate	Clemastine Fumarate	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Linzess	Linaclotide	22	suppressed
Hydrocortisone	Hydrocortisone	21	suppressed
Lactulose	Lactulose	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Icosapent Ethyl	Icosapent Ethyl	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Proctozone-Hc	Hydrocortisone	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	15
Dexlansoprazole Dr	Dexlansoprazole	19	suppressed
Fluocinonide	Fluocinonide	19	suppressed
Ozempic	Semaglutide	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Nateglinide	Nateglinide	14	suppressed
Olanzapine Odt	Olanzapine	14	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Carvedilol	Carvedilol	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Lumigan	Bimatoprost	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed
Trileptal	Oxcarbazepine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error